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EDITORIAL
Diabetic nephropathy: It’s in the numbers
Progressive renal disease is characterized by glomeru- laries. Recent studies have pointed to a primary impor-
losclerosis, tubulointerstitial fibrosis and vascular sclero- tance of peritubular capillary density, possibly modulated
sis. Tubulointerstitial fibrosis is assumed to be merely sec- by vascular endothelial derived growth factor (VEGF)
ondary to glomerular sclerosis with resulting ischemia to or other angiogenic factors in various progressive renal
the remaining nephron segment. Regardless of its etiology, diseases [7]. Future studies may demonstrate whether
interstitial fibrosis is recognized as an accurate marker these interstital microvascular lesions are causal or con-
of progressive decline in glomerular filtration rate (GFR) sequential in the development of interstitial injury in
in chronic renal diseases, including diabetic nephropathy diabetic nephropathy.
[1, 2]. This may relate in part to the larger sample of neph- In the study by Katz et al, lymphocytes and macro-
rons examined by assessing the tubulointerstitium, com- phages were increased in late stages of interstitial fibro-
pared to the relatively smaller number of glomeruli in hu- sis, as expected. Macrophages have diverse roles in tissue
man renal biopsies. Previous studies of the pathology of injury, mediating repair and remodeling after injury. Per-
human diabetic nephropathy from the Minnesota group sistence of activated macrophages is tightly correlated
and others have largely focused on the glomerular lesions. with progressive fibrosis in the kidney. However, ma-
These important studies have defined key functional- crophage infiltration is dissociated from fibrosis in the
structural relationships of mesangial matrix expansion absence of v6 integrin, an epithelial-expressed local
and decreased capillary filtration surface area with renal activator of transforming growth factor- (TGF-), sup-
dysfunction [3, 4]. porting that a parenchymal cell profibrotic response may
New data also have emerged to demonstrate the pli- be necessary to effect fibrosis [8]. Thus, macrophages
ability of sclerosing kidney tissue. Cure of patients’ dia- and tubular epithelial cells together may contribute to
betes mellitus by pancreas transplant has even demon- these later stages of fibrosis. The balance of extracellular
strated, by repeat renal biopsies, the possible regression matrix (ECM) synthesis versus degradation is influenced
of early glomerular as well as tubulointerstitial lesions by matrix metalloproteases and their inhibitors, the tis-
[5]. Sclerosis is not an end-stage static condition; rather it sue inhibitors of matrix metalloproteases (TIMPs), and
is a dynamic process with ongoing cell turnover and the plasmin/plasminogen activator system and its inhibi-
remodeling of extracellular matrix. The responsiveness tor, plasminogen activator inhibitor-1 (PAI-1). The net
of glomerular lesions to various experimental interven- effect may be remodeling and repair or interstitial fibro-
tions has been intensively investigated. However, these sis [9]. The potential role of these modulators of ECM
approaches have been limited by the lack of optimal metabolism in established diabetic interstitial lesions is
rodent models. Diabetic mice and rats do develop mesan- yet to be determined.
gial expansion, but true Kimmelstiel-Wilson nodules or An unexpected and interesting finding is the qualita-
interstitial fibrosis and progressive renal failure are lack- tive difference observed in the earliest interstitial lesion
ing. A recently launched NIDDK-funded consortium has versus more established lesions. The elegant, detailed
as its primary objective the development of a better morphometric analyses indicate an increase in interstitial
mouse model of diabetic nephropathy. In this issue of cell fractional volume at early stages, preceding the accu-
Kidney International, Katz et al show exciting new data mulation of interstitial collagen. This is in stark contrast
emphasizing the importance of the interstitial lesion [6]. to the time course of the diabetic mesangial lesion, where
These findings underscore the urgent need for better the expanded mesangial area is largely due to increased
tools to study the pathogenesis of interstitial lesions in matrix accumulation rather than hypercellularity. The
diabetic nephropathy. increased cell component of the interstitium was not
These timely new data expand our insights into the explained by infiltrating lymphocytes and macrophages,
dynamics of the tubulointerstitial injury mechanisms in which were rare in the early lesion. The precise nature
type I diabetes. Diabetes is broadly considered a micro-
of the interstitial cells in the early lesion has not been
vascular disease. Indeed, these morphometric studies dem-
identified in the current study, but will provide muchonstrated a decrease in abundance of peritubular capil-
interesting fuel for further studies. These cells could pos-
sibly represent myofibroblasts. In addition to infiltrating
macrophages, interstitial myofibroblasts are postulated
to play a key role in interstitial fibrosis. These activated 2002 by the International Society of Nephrology
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a marker of myofibroblasts, predicts progressive renal
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